Max Hennig
University of Jena
3 Papers
51 Citations
Max Hennig is an academic researcher from University of Jena. The author has contributed to research in topics: Flexural strength & Shear strength. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Microorganisms @ materials surfaces in aircraft: Potential risks for public health? – A systematic review
Bin Zhao,Carolin Dewald,Max Hennig,Jörg Bossert,Michael Bauer,Mathias W. Pletz,Klaus D. Jandt +6 more
TL;DR: The interior surfaces in seat and lavatory areas could pose higher health risks by causing infections due to their relatively high microbial contamination compared with other interior surfaces.
31
Effects of oxygen plasma treatment on interfacial shear strength and post-peak residual strength of a PLGA fiber-reinforced brushite cement.
Stefan Maenz,Max Hennig,Mike Mühlstädt,Elke Kunisch,Matthias Bungartz,Olaf Brinkmann,Jörg Bossert,Raimund W. Kinne,Klaus D. Jandt +8 more
TL;DR: This study shows for the first time that the matrix-fiber ISS and some of the resulting mechanical properties of fiber-reinforced CPCs can be improved by chemical modifications such as oxygen plasma treatment, generating the possibility of avoiding catastrophic failures at the implant site and thus enhancing the applicability of biodegradable CPCs for the treatment of (load-bearing) bone defects.
27
Decreased extrusion of calcium phosphate cement versus high viscosity PMMA cement into spongious bone marrow—an ex vivo and in vivo study in sheep vertebrae
Long Xin,Matthias Bungartz,Stefan Maenz,Victoria Horbert,Max Hennig,Bernhard Illerhaus,Jens Günster,Jörg Bossert,Sabine Bischoff,Juliane Borowski,Harald Schubert,Klaus D. Jandt,Elke Kunisch,Raimund W. Kinne,Olaf Brinkmann +14 more
TL;DR: Because of comparable compressive strength, but significantly lower cement extrusion into spongious bone marrow than PMMA cement, physiological CPC (+/- PLGA fibers) may represent an attractive alternative to PMMA for vertebroplasty or kyphoplasty of osteoporotic vertebral fractures to reduce the frequency or severity of adverse effects.
26